No Data
No Data
Major Stakeholder Makes a Bold Move With Imac Holdings Stock!
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Insider Purchase: 10% Owner at $BACK Buys 164,872 Shares
12 Health Care Stocks Moving In Thursday's After-Market Session
Ignite Proteomics, Subsidiary Of IMAC Holdings, Announces MHC-II Expression As Superior Predictor For Pembrolizumab Response Compared To PD-L1 Ahead Of NCCN Conference
Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference